Bio Green Med Solution (BGMS) Depreciation & Amortization (CF) (2010 - 2015)
Bio Green Med Solution (BGMS) posted quarterly Depreciation & Amortization (CF) of $1000.0 for Q1 2026, down 75.0% quarter-over-quarter from $4000.0 in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Depreciation & Amortization (CF) (2010 - 2015) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Depreciation & Amortization (CF) for 17 consecutive years, with $1000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) changed N/A year-over-year to $1000.0; the TTM figure through Mar 2026 stood at $5000.0 (up 25.0% YoY), while the FY2025 annual figure was $5000.0, down 16.67% from the prior year.
- Depreciation & Amortization (CF) slipped to $1000.0 in Q1 2026 per BGMS's latest filing, from $4000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $9000.0 in Q1 2022 and bottomed at $1000.0 in Q3 2024.
- Historically, Depreciation & Amortization (CF) has averaged $5285.7 across 5 years, with a median of $7000.0 in 2022.
- Annual changes were most pronounced in 2024 — Depreciation & Amortization (CF) sank 87.5% — and 2025, when it soared 300.0%.
- Bio Green Med Solution's Depreciation & Amortization (CF) stood at $8000.0 in 2022, then changed by 0.0% to $8000.0 in 2023, then tumbled by 87.5% to $1000.0 in 2024, then jumped by 300.0% to $4000.0 in 2025, then slumped by 75.0% to $1000.0 in 2026.
- Business Quant data shows BGMS's Depreciation & Amortization (CF) at $1000.0 in Q1 2026, $4000.0 in Q4 2025, and $1000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.23 Bn | 133.38 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.92 Bn | 78.92 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.52 Bn | 52.38 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.60 Bn | 44.60 Bn | - | - |
| 6 | BeOne Medicines | 40.47 Bn | 35.37 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.23 Bn | 27.40 Bn | - | - |
| 9 | Insmed | 27.37 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Bio Green Med Solution | 5.03 Mn | 1.24 Mn | 79,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 55,000.00 |
| Jun 30, 2015 | 50,000.00 |
| Mar 31, 2015 | 52,000.00 |
| Sep 30, 2014 | 69,000.00 |
| Jun 30, 2014 | 23,000.00 |
| Mar 31, 2014 | 23,000.00 |
| Dec 31, 2013 | 12,000.00 |
| Sep 30, 2013 | 22,000.00 |
| Jun 30, 2013 | 10,000.00 |
| Mar 31, 2013 | 26,000.00 |
| Dec 31, 2012 | 15,000.00 |
| Sep 30, 2012 | 15,000.00 |
| Jun 30, 2012 | 15,000.00 |
| Mar 31, 2012 | 15,000.00 |
| Dec 31, 2011 | -9,000.00 |
| Sep 30, 2011 | 78,000.00 |
| Jun 30, 2011 | 86,000.00 |
| Mar 31, 2011 | 86,000.00 |
| Dec 31, 2010 | 106,000.00 |
| Sep 30, 2010 | 111,000.00 |